PATENT CLAIM ANALYSIS

Application Number: 15860742
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.

Claim (Index 53):
The method of  claim 51 , wherein the one or more additional doses comprises a first and a second additional dose.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 86.0
- Lexical Diversity: 1.14286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13989119', '12786425', '14360137', '14077676', '15717849']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7754535149126294
- 35 USC 102 Novelty (BERT): 0.552796174202693
- Combined Prediction Score: 0.7531877808416357
- Mean Citation Score: 436.545452
- Max Citation Score: 451.64304
- Similarity Product: 248.3877407304096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test